NIR-based approach to counterfeit-drug detection

TrAC - Trends in Analytical Chemistry

Volumn 29, Issue 8, 2010, Pages 795-803

  Rodionova, Ye ^a   Pomerantsev, A L ^a,b  

^a SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

^b State South Research and Testing Site RAS   (Russian Federation)

Author keywords

Acceptance area; Active ingredient; Chemometrics; Counterfeit drug; Drug detection; Excipient; Genuine drug variability; Misclassification; Multivariate classification; Near infrared spectrometry

Indexed keywords

CRIME; DATA HANDLING; INFRARED DEVICES; INFRARED SPECTROSCOPY; NEAR INFRARED SPECTROSCOPY;

ACCEPTANCE AREA; ACTIVE INGREDIENTS; CHEMOMETRICS; COUNTERFEIT DRUGS; DRUG DETECTION; EXCIPIENT; GENUINE DRUG VARIABILITY; MISCLASSIFICATIONS; MULTIVARIATE CLASSIFICATION; NEAR INFRARED SPECTROMETRY;

BATCH DATA PROCESSING;

ANTIDEPRESSANT AGENT; ANTIMALARIAL AGENT; ATORVASTATIN; COTRIMOXAZOLE; DROTAVERINE; ILLICIT DRUG; METRONIDAZOLE; PANCREATIN; PIROXICAM; POLYETHYLENE; SILDENAFIL; TAURINE;

CHEMOMETRIC ANALYSIS; DRUG CLASSIFICATION; DRUG DETERMINATION; DRUG PACKAGING; DRUG QUALITY; DRUG RESEARCH; FILM COATING; INFORMATION PROCESSING; NEAR INFRARED SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVIEW; TABLET FORMULATION;

EID: 77955655793     PISSN: 01659936     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trac.2010.05.004     Document Type: Review

References (52)

1. http://www.emea.europa.eu/Inspections/Counterfeits.html.
2. World Health Organization (WHO), Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs, WHO, Geneva, Switzerland, 1999.
3. Deisingh A.K. Analyst (Cambridge, UK) 2005, 130:271.
4. Eliasson C., Matousek P. Anal. Chem. 2007, 79:1696.
5. Jähnke R.W. Pharm. Ind. 2004, 66:1187.
6. Dowell F.E., Maghirang E.B., Fernandez F.M., Newton P.N., Green M.D. J. Pharm. Biomed. Anal. 2008, 48:1011.
7. Neil A.T.O., Jee R.D., Lee G., Charvill A., Moffat A.C. J. NIR Spectrosc. 2008, 16:327.
8. J. Shaohong Jin, Roles and functions of Chinese Pharmacopoeia and Reference Standard in China drug administration, Paper, Conference, New Frontiers in the Quality of Medicines, France, 2008, pp. 44-46.
9. Scafi S.H.F., Pasquini C. Analyst (Cambridge, UK) 2001, 126:2218.
10. Rodionova O.Ye., Houmøller L.P., Pomerantsev A.L., Geladi P., Burger J., Dorofeyev V.L., Arzamastsev A.P. Anal. Chim. Acta 2005, 549:151.
11. Yoon W.L. Am. Pharm. Rev. 2005, 8:115.
12. Ricci C., Eliasson C., MacLeod N.A., Newton P.N., Matousek P., Kazarian S.G. Anal. Bioanal. Chem. 2007, 389:1525.
13. Moffat A.C. J. Pharm. Pharmacol. 2007, Supplement 1:A-26.
14. Dyrby M., Engelsen S.B., Norgard L., Bruhn M., Lundsberg-Nielsen L. Appl. Spectrosc. 2002, 56:579.
15. Trafford A.D., Jee R.D., Moffat A.C., Graham P. Analyst (Cambridge, UK) 1999, 124:163.
16. Laasonen M., Harmia-Pulkkinen T., Simard C., Rasanen M., Vuorela H. Anal. Chem. 2003, 75:754.
17. Chalus P., Roggo Y., Walter S., Ulmschneider M. Talanta 2005, 66:1294.
18. Lei Y., Luo Z.-Y., Hu C.-Q. J. NIR Spectrosc. 2008, 16:349.
19. Chong X.-M., Hu C.-Q., Feng Y.-C., Pang H.-H. Vib. Spectrosc. 2009, 49:196.
20. Baer I., Gurny R., Margot P. Forensic Sci. Int. 2007, 167:234.
21. Roggo Y., Chalus P., Maurer L., Lema-Martinez C., Edmond A., Jent N. J. Pharm. Biomed. Anal. 2007, 44:683.
22. World Health Assembly (WHA), Counterfeit drugs: Threat to Public Health, vol. 55, WHA, Geneva, Switzerland, 2002.
23. Dubois J., Wolff J.-C., Warrack J.K., Schoppelrei J., Lewis E.N. Spectroscopy (Amsterdam) 2007, 22:40.
24. Gendrin C., Roggo Y., Collet C. J. Pharm. Biomed. Anal. 2008, 48:533.
25. Ravn C., Skibsted E., Bro R. J. Pharm. Biomed. Anal. 2008, 48:554.
26. Amigo J.M., Cruz J., Bautista M., Maspoch S., Coello J., Blanco M. Trends Anal. Chem. 2008, 27:696.
27. Blanco M., Villarroya I. Trends Anal. Chem. 2002, 21:240.
28. Gabrielson J., Lindberg N.-O., Lundstedt T. J. Chemomet. 2002, 16:141.
29. Luypaert L., Massart D.L., Vander Heyden Y. Talanta 2007, 72:865.
30. Martens H., Naes T. Multivariate Calibration 1998, Wiley, New York, USA.
31. Naes T., Isaksson T., Fearn T., Davies T. Multivariate Calibration and Classification 2002, Wiley, Chichester, West Sussex, UK.
32. de Peinder P., Vredenbregt M.J., Visser T., de Kaste D. J. Pharm. Biomed. Anal. 2008, 47:688.
33. Derde M.P., Massart D.L. Anal. Chim. Acta 1986, 184:33.
34. Roggo Y., Degardin K., Margot P. Talanta 2010, 81:988.
35. Wold S. Pattern Recognition 1976, 8:127.
36. De Maesschalck R., Candolfi A., Massart D.L., Heuerding S. Chemom. Intell. Lab. Syst. 1999, 47:65.
37. Daszykowski M., Kaczmarek K., Stanimirova I., Vander Heyden Y., Walczak B. Chemom. Intell. Lab. Syst. 2007, 87:95.
38. Pomerantsev A.L. J. Chemomet. 2008, 22:601.
39. Rodionova O.Ye., Pomerantsev A.L. Proc. 11th Conf. Chemomet. Anal. Chem. (France) 2008, 3:123.
40. Luypaert J., Heuerding S., Vander Heyden Y., Massart D.L. J. Pharm. Biomed. Anal. 2004, 36:495.
41. Thennadil S.N., Martin E.B. J. Chemomet. 2005, 19:77.
42. Petri J., Kaunzinger A., Niemoller A., Karas M. Pharmazie 2005, 60:743.
43. Guo Q., Wu W., Massart D.L., Boucon C., de Jong S. Anal. Chim. Acta 2001, 446:85.
44. Broad N.W., Jee R.D., Moffat A.C., Eaves M.J., Mann W.C., Dziki W. Analyst (Cambridge, UK) 2000, 125:2054.
45. Rodionova O.Ye., Sokovikov Y.V., Pomerantseva A.L. Anal. Chim. Acta 2009, 642:222.
46. Hoskuldsson A. Chemom. Intell. Lab. Syst. 2001, 55:23.
47. Teofilo R.F., Martins J.P.A., Ferreira M.M.C. J. Chemometrics 2009, 23:32.
48. Abrahamsson C., Johansson J., Sparen A., Lindgren F. Chemom. Intell. Lab. Syst. 2003, 69:3.
49. Soh C.S., Raveendran P., Mukundan R. Chemom. Intell. Lab. Syst. 2008, 93:63.
50. Smith M.R., Jee R.D., Moffat A.C., Rees D.R., Broad N.W. Analyst (Cambridge, UK) 2003, 128:1312.
51. WU W., Walczak B., Massart D.L., Heuerding S., Erni F., Last I.R., Prebble K.A. Chemom. Intell. Lab. Syst. 1996, 33:35.
52. http://www.ema.europa.eu/pdfs/human/qwp/1776009endraft.pdf.